Department of Research, Bioface/PgO/UCAM, Calle Cuareim 1483, Montevideo 11100, Uruguay.
Instituto de Bioingenieria, Universidad Miguel Hernández, Avda. Ferrocarril s/n, 03202 Elche, Spain.
Medicina (Kaunas). 2023 Jul 5;59(7):1250. doi: 10.3390/medicina59071250.
: The primary objective of the present retrospective clinical study was to evaluate and compare the clinical performance presented by castable abutments developed for the MT system versus intermediate machined abutments, specifically regarding prosthetic or implant fractures/loss; the secondary objective was to verify the looseness of the abutments and the behavior of the peri-implant soft tissues. : This clinical retrospective study was conducted on patients rehabilitated between 2019 and 2020. Inclusion criteria were patients in good general health, with an implants-supporting single crown; with solid machined abutments (control group) or castable UCLA abutments; with a connection portion (base) machined in cobalt-chrome (test group) over Morse taper DuoCone implants in the posterior mandible area; and at least two years in function. Clinical assessment was carried out by the same professional, considering the following parameters: (A) prosthetic: (i) loosening of the fixation screw, (ii) fracture of the screw and (iii) the number of times the patient had some type of complication after the installation of the prostheses were evaluated; (B) biological: (i) without keratinized mucosa (KM), (ii) 1 mm or less, (iii) between 1 and 2 mm and (iv) greater than 2 mm of KM width; and the presence or absence of mucositis. Furthermore, radiographic evaluation was performed in order to assess the marginal bone loss. These evaluations permitted to compare the groups analyzed and patients enrolled. Data were statistically analyzed, with the level of significance set at α = 0.05. : 79 patients with 120 MT implants were evaluated (80 castable UCLA abutments and 40 machined solid abutments). The follow-up was from 2 to 4 years. There was a 100% implant survival rate. Therefore, the control group showed two fractured abutments (5%) and no abutment loosening (95% for prosthetic survival rate), whereas the test group showed no abutment fracture but nine loosening screws (11.3%) (100% for prosthetic survival rate). Keratinized mucosa was considered thin or absent in 19 implants in the control group (47.5%) and 42 in the test group (52.5%). Mucositis was found in 11 implants in the control group (27.5%) and 27 in the test group (33.8%). A positive correlation was observed between the width of keratinized mucosa and mucositis (r = 0.521, = 0.002). The mean marginal bone loss was 2.3 mm, ranging from 1.1 to 5.8 mm. No correlation was observed when considering marginal bone loss versus the three parameters (implant diameter, implant length and time of the prosthesis in function). : The results suggest that UCLA-type abutments are a viable option for rehabilitating implants with Morse taper connections, suggesting lower fracture risk. Further research is necessary to confirm these findings and thoroughly evaluate the clinical performance and long-term outcomes.
本回顾性临床研究的主要目的是评估和比较 MT 系统的可铸造基台与中间机械基台的临床性能,特别是在修复体或种植体骨折/丢失方面;次要目的是验证基台的松动情况和种植体周围软组织的情况。
本临床回顾性研究纳入了 2019 年至 2020 年期间接受治疗的患者。纳入标准为:一般健康状况良好、接受单冠种植体修复的患者;采用实心机械基台(对照组)或可铸造 UCLA 基台;在下颌后区采用 Morse 锥 DuoCone 种植体,连接部分(基底)采用钴铬机械加工(实验组);功能至少两年。临床评估由同一名专业人员进行,考虑以下参数:(A)修复体:(i)固定螺钉松动,(ii)螺钉断裂,(iii)患者在安装修复体后发生任何类型并发症的次数;(B)生物学:(i)无角化黏膜(KM),(ii)1 毫米或更少,(iii)1 至 2 毫米,(iv)KM 宽度大于 2 毫米;以及是否存在黏膜炎。此外,还进行了放射学评估,以评估边缘骨丢失情况。这些评估允许比较分析的组和纳入的患者。对数据进行了统计学分析,显著性水平设置为 α = 0.05。
共评估了 79 名患者的 120 个 MT 种植体(80 个可铸造 UCLA 基台和 40 个机械加工实心基台)。随访时间为 2 至 4 年。种植体的存活率为 100%。因此,对照组显示有两个基台断裂(5%),没有基台松动(修复体存活率为 95%),而实验组没有基台断裂,但有 9 个松动螺钉(11.3%)(修复体存活率为 100%)。对照组有 19 个种植体(47.5%)和 42 个种植体(52.5%)的角化黏膜较薄或缺失。对照组有 11 个种植体(27.5%)和实验组有 27 个种植体(33.8%)出现黏膜炎。角化黏膜的宽度与黏膜炎呈正相关(r = 0.521,p = 0.002)。平均边缘骨丢失为 2.3 毫米,范围为 1.1 至 5.8 毫米。考虑种植体直径、种植体长和修复体使用时间这三个参数时,边缘骨丢失与它们之间无相关性。
结果表明,UCLA 型基台是 Morse 锥连接种植体修复的一种可行选择,其骨折风险较低。需要进一步的研究来证实这些发现,并对其临床性能和长期结果进行全面评估。